DNLI

DENALI THERAPEUTICS INC

Healthcare | Mid Cap

-$0.72

EPS Forecast

$15.43

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2025-09-30
RGENRepligen CorpNBIXNeurocrine Biosciences IncMRNAModerna IncCRSPCrispr Therapeutics AgHALOHalozyme Therapeutics IncNVAXNovavax IncREPLReplimune Group IncTECHBio-techne CorpIOVAIovance Biotherapeutics Inc